Web Stats Provided By Google Analytics

The Raw Stem Cell News Feed

The Stem Cell Research Newswire: Comprehensive Real-Time News Feed for Stem Cell Research

Thursday, March 12, 2015

Neuralstem reports top line data from NSI-566 Phase II trial for treatment of ALS

Neuralstem, Inc. announced top line data from the Phase II trial of NSI-566 spinal cord-derived neural stem cells under development for the treatment of amyotrophic lateral sclerosis . The study met primary safety endpoints.

http://ift.tt/1L1qlrt
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Popular Stem Cell Roundup Posts